Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
07:00am, Monday, 18'th Nov 2024
MINNEAPOLIS , Nov. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease re
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
07:00am, Thursday, 14'th Nov 2024
Customers will present data from their use of novel assays and kits; company will host educational workshops and discussions for attendees MINNEAPOLIS , Nov. 14, 2024 /PRNewswire/ -- Bio-Techne Corpor
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
05:47pm, Monday, 11'th Nov 2024
R&D Systems Hematology Controls and Calibrators has completed the Class B Certification under the new European Union In Vitro Diagnostic Regulation This press release updates the IVDR Classification
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
07:00am, Monday, 11'th Nov 2024
R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation MINNEAPOLIS , Nov. 11, 2024 /PRNewswire/ -- Bio-Te
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
07:00am, Friday, 08'th Nov 2024
MINNEAPOLIS , Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: UBS Global Healthcare Conference November 1
ST. PAUL, Minn. , Nov. 7, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation and CellReady, has awarded G-Rex Grants totaling $475,000 to three
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
07:00am, Wednesday, 06'th Nov 2024
MINNEAPOLIS , Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to pers
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
07:00am, Tuesday, 05'th Nov 2024
MINNEAPOLIS , Nov. 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of clinically relevant spatial biology data. The data was generated using Bio-Techne's Luna
Bio-Techne Corporation (TECH) Q1 2025 Earnings Call Transcript
03:48pm, Wednesday, 30'th Oct 2024
Bio-Techne Corporation (NASDAQ:TECH ) Q1 2025 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President and Ch
Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket
01:05pm, Wednesday, 30'th Oct 2024
TECH registers continued momentum across its Diagnostics & Spatial Biology segment.
Techne (TECH) Beats Q1 Earnings and Revenue Estimates
08:45am, Wednesday, 30'th Oct 2024
Techne (TECH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.41 per share a year ago.
Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise
07:49am, Wednesday, 30'th Oct 2024
Bio-Techne beat first-quarter profit estimates on Wednesday helped by growth in its diagnostics and spatial biology segment, sending the shares of the biotech company up 4.59% in premarket trading.
BIO-TECHNE DECLARES DIVIDEND
06:30am, Wednesday, 30'th Oct 2024
MINNEAPOLIS , Oct. 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended Septemb
BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
06:30am, Wednesday, 30'th Oct 2024
MINNEAPOLIS , Oct. 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024. First Quarter FY2025 Highlights F
What to Expect From These 3 MedTech Stocks This Earnings Season
12:31pm, Tuesday, 29'th Oct 2024
Here is a sneak peek into how three MedTech companies, ZBH, BIO and TECH, are expected to fare in their upcoming quarterly results, slated to be released tomorrow.
